Syntegra Partners with TMA Precision Health to Reduce the Diagnostic Odyssey for Rare Disease with Synthetic Data-Enabled Tools

SAN FRANCISCO, June 14, 2022 /PRNewswire/ -- Syntegra, a leader in synthetic healthcare data generation, today announced a partnership with TMA Precision Health (TMA), a StartUp Health platform for rare diseases, aimed at using synthetic data to improve the diagnosis of rare disease...

Click to view original post